US Patent Issued to Ospedale San Raffaele, Fondazione Telethon on Sept. 8 for "Compositions and methods for haematopoietic stem cell transplantation" (Italian Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,371, issued on Sept. 8, was assigned to Ospedale San Raffaele S.r.l. (Milan) and Fondazione Telethon (Rome).

"Compositions and methods for haematopoietic stem cell transplantation" was invented by Claire Latroche (Milan), Luigi Naldini (Milan) and Maura Manzi (Milan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Use of CD47 and/or C-X-C chemokine receptor type 4 (CXCR4) for increasing engraftment by haematopoietic stem and/or progenitor cells (HSPCs)."

The patent was filed on May 16, 2019, under Application No. 17/250,050.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=P...